Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells-Reference-Cited by-同舟云学术

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Published:2017-05 Issue: Volume:393 Page:52-59
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Klampatsa Astero,Achkova Daniela Y.,Davies David M.,Parente-Pereira Ana C.,Woodman Natalie,Rosekilly James,Osborne Georgina,Thayaparan Thivyan,Bille Andrea,Sheaf Michael,Spicer James F.,King Juliet,Maher John^ORCID

Funder

June Hancock Mesothelioma Research Fund

British Lung Foundation

National Institute for Health Research

Guy's and St Thomas' NHS Foundation Trust

King's College London

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Asbestos bodies and mesothelioma;Stumphius;Ann. Occup. Hyg.,1968

2. Malignant mesothelioma: global incidence and relationship with asbestos;Bianchi;Ind. Health,2007

3. Local and systemic therapies for malignant pleural mesothelioma;Gomez;Curr. Treat. Options Oncol.,2014

4. Chemotherapy options and new advances in malignant pleural mesothelioma;Steele;Ann. Oncol.,2005

5. New roads open up for implementing immunotherapy in mesothelioma;Cornelissen;Clin. Dev. Immunol.,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming efficiency limitations of CAR-T cell therapy in antigen-heterogeneous solid tumors;Expert Opinion on Biological Therapy;2024-09-02

2. Recent Advances and Challenges in Cancer Treatment with Car T Cell Therapy: A Novel Anti-cancer Strategy;BioNanoScience;2024-04-09

3. Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma;International Journal of Food Sciences and Nutrition;2023-09-03

4. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments;Journal of Translational Medicine;2023-07-07

5. Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy;Cancers;2023-07-03